nLIGHT Has Lost 39% in 3 Months: Northcoast Sees 88% Upside
nLIGHT (LASR) has fallen 39% in three months due to delayed shipments from Chinese suppliers. Northcoast Research upgraded it to Buy with a $75 price target, 88% above its Oct. 7 close, citing valuation. The target is the lowest among analysts, who expect earnings to more than double by 2026.
How this was made
The 30-second read
Why it matters
The analyst upgrade introduces a new upside catalyst, but the supply‑chain issue remains a material risk that could suppress earnings and stock performance in the short term.
Market read
The article provides fresh analyst coverage and guidance details for a small‑cap defense laser company, offering a potential trade idea amid supply‑chain concerns.
What to watch
Potential for the JLWS contract to offset revenue shortfall if execution proceeds smoothly.
Background
nLIGHT (LASR) reported record Q2 revenue but warned that Q3 guidance excludes $17 million of expected product revenue due to parts held up in China, prompting a sharp share decline and an analyst upgrade.
Ticker impact
Northcoast Research upgraded nLIGHT to Buy on Oct. 7 with a $75 price target, 88% above the close, after the company issued Q3 guidance that omitted $17 million of product revenue due to Chinese supply‑chain delays.
possible upward pressure as investors price in the new $75 target, tempered by supply‑chain concerns that may limit near‑term gains
The fresh upgrade provides a concrete catalyst, yet the underlying supply‑chain delay and recent share sell‑off introduce uncertainty.
Market effects
Highlights supply‑chain risk for laser and defense manufacturers reliant on Chinese components.
May affect other US‑listed defense tech stocks with similar exposure.
Signals broader concerns about China‑US supply‑chain tensions in high‑tech sectors.
Counterpoint
The supply‑chain delay could worsen, making the $75 target overly optimistic.
Key entities
- AnalystNorthcoast Research
Upgraded nLIGHT to Buy with a $75 price target.
- CEOScott Keeney
Stated that guidance would have been higher without supply‑chain challenges.



